The diagnosis and differential diagnosis of dementia

Medical Clinics of North America

Volumn 86, Issue 3, 2002, Pages 455-476

  Ross, G Webster ^a   Bowen, James D ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; APHASIA; BRAIN RADIOGRAPHY; CLINICAL EXAMINATION; COGNITIVE DEFECT; DELIRIUM; DEMENTIA; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL ASSESSMENT; HUMAN; INFECTION; LABORATORY TEST; MENTAL HEALTH; METABOLIC DISORDER; MULTIINFARCT DEMENTIA; NORMOTENSIVE HYDROCEPHALUS; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SUBDURAL HEMATOMA;

AGED; AGING; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTELLIGENCE TESTS; MEMORY DISORDERS;

EID: 0036329683     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00009-3     Document Type: Review

References (86)

1. Cognitive function and the costs of Alzheimer disease. An exploratory study
2. Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported
3. The economic burden of Alzheimer's disease care
4. Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study
5. Documentation and evaluation of cognitive impairment in elderly primary care patients
6. Clinical Diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
7. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
8. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening tool for dementia for a predominantly illiterate Chinese population
9. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms
10. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
11. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment
12. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
13. Measurement of functional activities in older adults in the community
14. Assessment of older people: Self-maintaining and instrumental activities of daily living
15. Diagnosis and evaluation of dementia
16. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
17. Speech and language alterations in dementia syndromes: Characteristics and treatment
18. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
19. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia
20. A new rating scale for Alzheimer's disease
21. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part 1: Clinical and neuropsychological assessment of Alzheimer's disease
22. Population-based norms for the Mini-Mental State Examination by age and educational level
23. The effects of childhood residence in Japan and testing language on cognitive performance in late life among Japanese American men in Hawaii
24. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
25. Practice parameter for diagnosis and evaluation of dementia (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology
26. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia
27. Evaluation of dementia: A systematic study of the usefulness of the American Academy of Neurology's practice parameters
28. Neuroimaging in dementia
29. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies
30. Memory function in normal aging
31. Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation
32. Selective decline in memory function among healthy elderly
33. A prospective study of cognitive function and onset of dementia in cognitively healthy elders
34. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
35. Of MCI and dementia: Improving diagnosis and treatment
36. Depression and memory impairment: A meta-analysis of the association, its pattern, and specificity
37. Memory complaints in older adults. Fact or fiction?
38. A rating scale for depression
39. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version
40. Distinction between preclinical Alzheimer's disease and depression
41. Delirium
42. Progression to dementia in patients with isolated memory loss
43. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State. The Kame Project
44. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease
45. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type
46. Clinical subtypes of dementia of the Alzheimer type
47. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
48. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
49. Clinical and neuropathological criteria for frontotemporal dementia
50. Frontotemporal dementia (Pick's disease): Clinical features and assessment
51. Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics
52. Intellectual impairment in Parkinson's disease: Clinical, pathologic, and biochemical correlates
53. The dementia syndrome of Parkinson's disease: Cortical and subcortical features
54. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
55. Report of the Second Dementia with Lewy body International Workshop: Diagnosis and treatment
56. Progressive supranuclear palsy
57. Multi-system atrophy-the nature of the beast
58. Vascular parkinsonism
59. Cortical-basal ganglionic degeneration
60. Causes, epidemiology, and risk factors of chronic subdural hematoma
61. Chronic subdural hematoma in adult and elderly patients
62. Clinical features of chronic subdural hematoma: Neuropsychiatric and neuropsychologic, changes in patients with chronic subdural hematoma
63. Nonoperative treatment of chronic subdural hematoma
64. Treatment of chronic subdural hematoma by burr holes and closed-system drainage
65. Alcoholic dementia
66. Drug-induced cognitive impairment. Defining the problem and finding solutions
67. The reversible dementias: Do they reverse?
68. Adverse drug reactions associated with global cognitive impairment in elderly persons
69. Dementia in elderly outpatients: A prospective study
70. Cerebral manifestations of vitamin-B12 deficiency
71. Megaloblastic madness
72. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis
73. Vitamin B12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function
74. Clinical practice. Subclinical hypothyroidism
75. Ten-year incidence of dementia in a rural elderly US community population: The MoVIES Project
76. Normal pressure hydrocephalus: Developments in determining surgical prognosis
77. Prognosis of dementia in normal-pressure hydrocephalus after a shunt operation
78. Diagnosis and management of normal-pressure hydrocephalus